Diet: Clinical Trials

43 trials of Diet, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 4 terminated, 4 unknown, 1 recruiting. 43 Phase 3, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 343Completed 33, Terminated 4, Unknown 4, Recruiting 1, Withdrawn 1
Phase 27Completed 5, Recruiting 1, Unknown 1

Follow Diet: new trials by email Literature Review of Diet trials Research Report on Diet

Trials (filtered) newest first · largest first

All 43 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction
Low calorie meal replacement plan, Cardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopy, Transthoracic echocardiography - Heart Failure With Preserved Ejection Fraction, Heart Failure, Diastolic
Phase 2 / Phase 3CompletedUniversity of Leicester662023-12-052026-07-22
Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects
Lifestyle Intervention, Dasatinib 100 MG, Quercetin 1000mg - Obesity, Healthy Lifestyle
Phase 2 / Phase 3RecruitingCedars-Sinai Medical Center1602023-10-172026-03-18
Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira
IDegLira, insulin degludec, Metformin - Type 2 Diabetes Mellitus
Phase 3CompletedPopulation Health Research Institute1592019-04-232023-10-25
Survival Benefits of Statins in Breast Cancer Patients
statins, Dietary intervention group (control group) - Breast Cancer Female
Phase 3UnknownPeking Union Medical College Hospital3142019-03-282019-08-14
Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101)
Diet - Leukemia, Myelodysplastic Syndromes
Phase 3TerminatedUniversity of Florida2172017-08-182025-04-07
Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi
iGlarLixi, Insulin Glargine, Metformin - Type 2 Diabetes Mellitus
Phase 3CompletedPopulation Health Research Institute1612017-06-272020-11-13
Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)
insulin glargine, sitagliptin/metformin, lifestyle therapy - Type 2 Diabetes Mellitus
Phase 3CompletedPopulation Health Research Institute1022016-07-092022-03-25
Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin
Alirocumab, Placebo, Atorvastatin - Hypercholesterolemia
Phase 3CompletedSanofi1632015-11-302019-01-23
Weight Loss and Appetite Reduction After Percutaneous Electrical Stimulation Dermatome T6
PENS T6, TENS T11/T12, Hypocaloric 1200 Kcal/day diet - Weight Loss
Phase 3CompletedHospital General Universitario Elche2002015-07-012016-06-23
PENS T6 With Ambulatory Self-applied Patch vs Conventional Procedure
Self-applied patch, Conventional procedure, 1200 Kcal/day diet - Weight Loss
Phase 3CompletedAbdel Kadar Clinic902015-07-012015-10-01
Effects of Self-conditioning Techniques in Promoting Weight Loss in Patients With Obesity. A Randomized Controlled Trial
self-conditioning techniques, standard care (diet, exercise and behavioral therapy) - Obesity
Phase 3CompletedUniversity of Turin, Italy1202015-02-012018-01-24
Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease
Diet and water adjustment - Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase 2 / Phase 3CompletedTufts Medical Center342014-05-012017-03-30
Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention
Diet, Physical activity, Minimal diet intervention - Breast Neoplasms, Recurrence
Phase 3UnknownInstitut Català d'Oncologia20002014-01-012014-01-14
Preoperative Diet Before Sleeve Gastrectomy
Regular diet, High protein formula, Immunonutrition - Pain
Phase 3CompletedHospital General Universitario Elche602014-01-012015-03-27
Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)
Alirocumab, Placebo (for Alirocumab), Non-statin LMT - Hypercholesterolemia
Phase 3CompletedSanofi2332013-12-162018-07-27
Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients
Percutaneous Neurostimulation (PENS) of dermatome T7, 1200 Kcal diet - Diabetes Mellitus Type 2 in Obese, Type 2 Diabetes Mellitus With Features of Insulin Resistance
Phase 3CompletedHospital General Universitario Elche602013-01-012014-04-25
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
Ranolazine, Placebo to match ranolazine, Metformin - Type 2 Diabetes Mellitus
Phase 3CompletedGilead Sciences4422012-06-012014-09-23
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Ranolazine, Placebo, Glimepiride - Type 2 Diabetes Mellitus
Phase 3CompletedGilead Sciences4312012-01-012014-11-18
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Ranolazine, Placebo, Diet - Type 2 Diabetes Mellitus
Phase 3CompletedGilead Sciences4652011-11-012014-10-24
Low Energy Dense, Weight Maintenance, Risk of Cardiovascular Disease
low energy dense, control, diet - Body Weight Decreased
Phase 3CompletedIsfahan University of Medical Sciences352011-01-012012-08-08

Showing 20 of 43. Sign in to see all of them.

Conditions studied

Diabetes Mellitus, Type 2 (12)  ·  Obesity (12)  ·  Cardiovascular Diseases (7)  ·  Diabetes Mellitus (5)  ·  Heart Diseases (5)  ·  Weight Loss (5)  ·  Motor Activity (4)  ·  Hypertension (3)  ·  Insulin Resistance (3)  ·  Breast Neoplasms (2)  ·  Hypercholesterolemia (2)  ·  Inflammation (2)  ·  Vascular Diseases (2)  ·  Anemia (1)  ·  Atherosclerosis (1)

Sponsors

Gilead Sciences (3)  ·  Hospital General Universitario Elche (3)  ·  Population Health Research Institute (3)  ·  Sanofi (3)  ·  AstraZeneca (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  Washington University School of Medicine (2)  ·  5 Santé (1)  ·  Abdel Kadar Clinic (1)  ·  Ben-Gurion University of the Negev (1)  ·  Boston Medical Center (1)  ·  Cedars-Sinai Medical Center (1)  ·  Chiang Mai University (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Hoffmann-La Roche (1)

Countries

United States (14)  ·  Canada (6)  ·  Czechia (4)  ·  Hungary (4)  ·  Poland (4)  ·  Russia (4)  ·  Australia (3)  ·  Slovakia (3)  ·  South Africa (3)  ·  Spain (3)  ·  Ukraine (3)  ·  China (2)  ·  France (2)  ·  Israel (2)  ·  Japan (2)

Top investigators

Dennis T Villareal, MD (2)  ·  Hertzel Gerstein, MD (2)  ·  Natalia McInnes, MD (2)  ·  Patrick Yue, MD (2)  ·  Adam G Tsai, MD, MSCE (1)  ·  Agnes Floeel, MD (1)  ·  Antonio Agudo, MD (1)  ·  Beatriz Cirauqui Cirauqui, MD (1)  ·  Bernd E Ringelstein, MD, Prof (1)  ·  Caroline M. Apovian, MD (1)  ·  Charles Hennekens (1)  ·  David W Sparrow, DSc (1)

Results publications

PMID 16636211, PMID 17327309, PMID 20151996, PMID 20187965, PMID 21449785, PMID 21689398, PMID 21786319, PMID 22424822, PMID 23630244, PMID 24451612, PMID 24787497, PMID 24947878, PMID 26049552, PMID 26358120, PMID 27289457, PMID 27625344, PMID 28432513, PMID 28951766, PMID 30013511, PMID 30226009, PMID 30458856, PMID 30509509, PMID 33512717, PMID 34728531, PMID 39356039, PMID 39880434, PMID 41406403

NIH funding

K24DK065018 (1), R01AG025501 (1), R01AG075684 (1), R01HL034767 (1), R01HL036821 (1), R01HL079483 (1), U01HL037852 (1), U01HL039870 (1)